ADA 2018

In this Exclusive Interview, Katherine Kreider talks with Diabetes in Control Publisher Steve Freed during the ADA 2018 convention in Orlando about diabetes distress.

In part 1 of this Exclusive Interview, Kathryn Kreider talks with Diabetes in Control Publisher Steve Freed about the interventions that can help with diabetes distress.

In part 2 of this Exclusive Interview, Kathryn Kreider talks with Diabetes in Control Publisher Steve Freed about the signs of diabetes distress and the impact of this distress on A1C.

In part 3 of this Exclusive Interview, Kathryn Kreider explains how diabetes distress is assessed in a discussion with Diabetes in Control Publisher Steve Freed.

In part 4 of this Exclusive Interview, Kathryn Kreider talks with Diabetes in Control Publisher Steve Freed about the two main steps to treating diabetes distress.

In part 5 of this Exclusive Interview, Kathryn Kreider talks with Diabetes in Control Publisher Steve Freed about the differences between depression and distress, and clinical methods for dealing with diabetes distress.

In part 6 of this Exclusive Interview, Kathryn Kreider talks with Diabetes in Control Publisher Steve Freed about when to look for diabetes distress in a newly diagnosed patient and further along in the patient's experience.

In part 7, the conclusion of this Exclusive Interview, Kathryn Kreider talks with Diabetes in Control Publisher Steve Freed about the use of technology to help patients experiencing diabetes distress.

Andrea Dunaif, M.D., is the Lillian and Henry M. Stratton Professor of Molecular Medicine and Chief of the J. Lester Gabrilove Division of Endocrinology, Diabetes and Bone Disease at the Icahn School of Medicine at Mount Sinai, New York, NY. Dr. Dunaif is an internationally recognized expert in endocrinology and women’s health. Her research on polycystic ovary syndrome (PCOS), the most common hormonal disorder of reproductive-age women, has shown that it is a leading risk factor for type 2 diabetes mellitus. Further, this research has revolutionized the treatment of PCOS with insulin sensitizing drugs.

In this Exclusive Interview transcript, Andrea Dunaif talks with Diabetes in Control Medical Editor Joy Pape during the ADA 2018 convention in Orlando about the relation of Polycystic Ovarian Syndrome to diabetes, its causes, diagnosis, and even the inaccuracy of the name.